Prescient Therapeutics Limited (ASX:PTX)
Australia · Delayed Price · Currency is AUD 0.0850
+0.0030 (3.66%)
Jul 31, 2026, 4:10 PM AEST
Prescient Therapeutics Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | -8.86 | -7.32 | -8.24 | -7 | -5.12 | -4.15 |
Depreciation & Amortization | -0.01 | -0.01 | 0 | 0 | 0 | 0 |
Asset Writedown & Restructuring Costs | - | - | 1.72 | - | - | - |
Stock-Based Compensation | 0.35 | 0.35 | 0.21 | 0.46 | 0.88 | 0.65 |
Other Operating Activities | 0.8 | 0.01 | 0.02 | 0.01 | -0.06 | 0.04 |
Change in Accounts Receivable | -0.05 | -0.05 | 0 | -0.13 | -0.02 | -0.02 |
Change in Accounts Payable | 0.09 | 0.09 | -0.06 | 1.16 | 0.39 | -0.39 |
Change in Other Net Operating Assets | -0.31 | -0.31 | -1.06 | -0.69 | -0.39 | -0.1 |
Operating Cash Flow | -8 | -7.24 | -7.4 | -6.19 | -4.31 | -3.97 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Capital Expenditures | - | - | - | - | -0 | -0 |
Investment in Securities | 4 | 4 | 12 | -16 | - | - |
Other Investing Activities | -2 | - | - | - | - | - |
Investing Cash Flow | 2 | 4 | 12 | -16 | -0 | -0 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Short-Term Debt Issued | - | - | - | - | - | 0.01 |
Long-Term Debt Issued | - | - | 0.02 | - | - | - |
Total Debt Issued | 0.27 | - | 0.02 | - | - | 0.01 |
Short-Term Debt Repaid | - | - | - | - | -0.17 | - |
Long-Term Debt Repaid | - | -0.33 | - | - | - | - |
Total Debt Repaid | -0.08 | -0.33 | - | - | -0.17 | - |
Net Debt Issued (Repaid) | 0.19 | -0.33 | 0.02 | - | -0.17 | 0.01 |
Issuance of Common Stock | 9.85 | - | - | 16.53 | 0.59 | 13.58 |
Other Financing Activities | -0.68 | - | - | -0.7 | - | -0.84 |
Financing Cash Flow | 9.35 | -0.33 | 0.02 | 15.83 | 0.43 | 12.75 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Foreign Exchange Rate Adjustments | 0.01 | -0.01 | -0.02 | -0.01 | 0.06 | -0.04 |
Net Cash Flow | 3.36 | -3.59 | 4.6 | -6.37 | -3.83 | 8.74 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Free Cash Flow | -8 | -7.24 | -7.4 | -6.19 | -4.32 | -3.97 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -187.48% | -166.27% | -199.28% | -254.97% | -228.50% | -335.08% |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Levered Free Cash Flow | -4.78 | -4.94 | -5.72 | -3.84 | -2.4 | -2.52 |
Unlevered Free Cash Flow | -4.78 | -4.94 | -5.72 | -3.84 | -2.4 | -2.52 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash Income Tax Paid | - | -3.71 | -2.37 | -1.64 | -1.3 | -1.03 |
Change in Working Capital | -0.28 | -0.28 | -1.11 | 0.34 | -0.03 | -0.51 |